Sun Pharmaceutical
PharmaLarge capNSE: SUNPHARMA · ₹4.18 L Cr market cap
₹1,742
-1.98%Price chart
Simulated series for demonstration
About the company
Sun Pharmaceutical operates in the pharma sector and is classified as a large-cap company with a market capitalisation of ₹4.18 L Cr. Reported return on equity is 6.3% with revenue growth of 30.5% and a debt-to-equity ratio of 0.95. Company descriptions and figures shown here are sample data for demonstration.
Volume
170 L
Beta
0.90
Dividend yield
4.61%
6M momentum
52.4%
Analyst context
Aggregated sample view
- Coverage24 analysts
- Consensus stanceConstructive
- Range of estimates1,481–2,090
Analyst estimates describe other people's expectations. They are not a forecast by ArthVue and are not a recommendation.
Market investments are subject to market risks. Past performance is not indicative of future results. Nothing here is investment advice.